OOIR: Observatory of International Research

Papers

(The H4-Index of Respirology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Global burden of sleep‐disordered breathing and its implications	138
Radiotherapy treatment for lung cancer: Current status and future directions	135
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong	111
Summarizing societal guidelines regarding bronchoscopy during the COVID‐19 pandemic	82
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact	66
Video‐assisted thoracoscopic surgery as the gold standard for lung cancer surgery	61
COVID‐19 infection and the broader impacts of the pandemic on healthcare workers	61
One‐year follow‐up CT findings in COVID‐19 patients: A systematic review and meta‐analysis	60
ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma	56
Pulmonary alveolar proteinosis	45
Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*	44
Natural history and mechanisms of COPD	44
Rationale for universal face masks in public against COVID‐19	43
Current global perspectives on silicosis—Convergence of old and newly emergent hazards	39
Air pollution and the pandemic: Long‐term PM_2.5 exposure and disease severity in COVID‐19 patients	39
Pulmonary toxicity of systemic lung cancer therapy	39
Pathophysiology of infection with SARS‐CoV‐2—What is known and what remains a mystery	35
Clusters of sleep apnoea phenotypes: A large pan‐European study from the European Sleep Apnoea Database (ESADA)	35
Exercise training as part of lung cancer therapy	34
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand	34
Occupational COPD—The most under‐recognized occupational lung disease?	33
Effect of comorbid pulmonary disease on the severity of COVID‐19: A systematic review and meta‐analysis	31
Cost of hospitalization for bronchiectasis exacerbation in children	31
Delay or avoidance of routine, urgent and emergency medical care due to concerns about COVID‐19 in a region with low COVID‐19 prevalence: Victoria, Australia	30
Stearic acid attenuates profibrotic signalling in idiopathic pulmonary fibrosis	30

Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression	29
Is tissue still the issue in detecting molecular alterations in lung cancer?	29
Treatable traits in the NOVELTY study	29
Lung cancer screening implementation: Complexities and priorities	28
Coagulation markers as predictors for clinical events in COPD	28
Characteristics of bronchiectasis in Korea: First data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries	28